|
|
|||||||||||
1 Registrar, Bellsdyke Hospital, Larbert.(Assistant Psychiatrist, Gartloch Hospital, Glasgow.)
2 Principal Clinical Psychologist, Bellsdyke Hospital, Larbert
A controlled trial concerning abrupt withdrawal of perphenazine in chronic schizophrenic patients in hospital is reported. A special feature is the use of two types of control group, enabling the relative importance of pharmacological and placebo effects to be assessed. Advantages of this method are discussed, and implications regard-the feasibility of discontinuous perphenazine treatment are drawn.
This article has been cited by other articles:
![]() |
A. Hrobjartsson and P. C. Gotzsche Is the Placebo Powerless?- An Analysis of Clinical Trials Comparing Placebo with No Treatment N. Engl. J. Med., May 24, 2001; 344(21): 1594 - 1602. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Paul, L. L. Tobias, and B. L. Holly Maintenance Psychotropic Drugs in the Presence of Active Treatment Programs: A "Triple-Blind" Withdrawal Study With Long-Term Mental Patients Arch Gen Psychiatry, July 1, 1972; 27(1): 106 - 115. [Abstract] [PDF] |
||||
![]() |
R. S. GANTZ and D. P. BIRKETT Phenothiazine Reduction As a Cause of Rehospitalization Arch Gen Psychiatry, June 1, 1965; 12(6): 586 - 588. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |